_version_ 1785090696814788608
author Lakhwani, Sunil Lakhwani
Santana, Ignacio Artiles
Pérez-Pinilla, Belén
Garcia, Alvaro Bienert
Saavedra, Minerva Montalvo
Díaz-Lopez, Marta
De Bonis-Braun, Carolina
Salazar, María José Rodríguez
Machado-Machado, Patricia
Garcia, Miguel Teodoro Hernandez
Raya, Jose Maria
author_facet Lakhwani, Sunil Lakhwani
Santana, Ignacio Artiles
Pérez-Pinilla, Belén
Garcia, Alvaro Bienert
Saavedra, Minerva Montalvo
Díaz-Lopez, Marta
De Bonis-Braun, Carolina
Salazar, María José Rodríguez
Machado-Machado, Patricia
Garcia, Miguel Teodoro Hernandez
Raya, Jose Maria
author_sort Lakhwani, Sunil Lakhwani
collection PubMed
description
format Online
Article
Text
id pubmed-10429374
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104293742023-08-17 PB2353: PROGNOSTIC VALUE OF TIME FROM SYMPTOMS BEGIN TO START TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA Lakhwani, Sunil Lakhwani Santana, Ignacio Artiles Pérez-Pinilla, Belén Garcia, Alvaro Bienert Saavedra, Minerva Montalvo Díaz-Lopez, Marta De Bonis-Braun, Carolina Salazar, María José Rodríguez Machado-Machado, Patricia Garcia, Miguel Teodoro Hernandez Raya, Jose Maria Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429374/ http://dx.doi.org/10.1097/01.HS9.0000976128.37753.23 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Lakhwani, Sunil Lakhwani
Santana, Ignacio Artiles
Pérez-Pinilla, Belén
Garcia, Alvaro Bienert
Saavedra, Minerva Montalvo
Díaz-Lopez, Marta
De Bonis-Braun, Carolina
Salazar, María José Rodríguez
Machado-Machado, Patricia
Garcia, Miguel Teodoro Hernandez
Raya, Jose Maria
PB2353: PROGNOSTIC VALUE OF TIME FROM SYMPTOMS BEGIN TO START TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA
title PB2353: PROGNOSTIC VALUE OF TIME FROM SYMPTOMS BEGIN TO START TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA
title_full PB2353: PROGNOSTIC VALUE OF TIME FROM SYMPTOMS BEGIN TO START TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA
title_fullStr PB2353: PROGNOSTIC VALUE OF TIME FROM SYMPTOMS BEGIN TO START TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA
title_full_unstemmed PB2353: PROGNOSTIC VALUE OF TIME FROM SYMPTOMS BEGIN TO START TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA
title_short PB2353: PROGNOSTIC VALUE OF TIME FROM SYMPTOMS BEGIN TO START TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA
title_sort pb2353: prognostic value of time from symptoms begin to start treatment in diffuse large b-cell lymphoma
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429374/
http://dx.doi.org/10.1097/01.HS9.0000976128.37753.23
work_keys_str_mv AT lakhwanisunillakhwani pb2353prognosticvalueoftimefromsymptomsbegintostarttreatmentindiffuselargebcelllymphoma
AT santanaignacioartiles pb2353prognosticvalueoftimefromsymptomsbegintostarttreatmentindiffuselargebcelllymphoma
AT perezpinillabelen pb2353prognosticvalueoftimefromsymptomsbegintostarttreatmentindiffuselargebcelllymphoma
AT garciaalvarobienert pb2353prognosticvalueoftimefromsymptomsbegintostarttreatmentindiffuselargebcelllymphoma
AT saavedraminervamontalvo pb2353prognosticvalueoftimefromsymptomsbegintostarttreatmentindiffuselargebcelllymphoma
AT diazlopezmarta pb2353prognosticvalueoftimefromsymptomsbegintostarttreatmentindiffuselargebcelllymphoma
AT debonisbrauncarolina pb2353prognosticvalueoftimefromsymptomsbegintostarttreatmentindiffuselargebcelllymphoma
AT salazarmariajoserodriguez pb2353prognosticvalueoftimefromsymptomsbegintostarttreatmentindiffuselargebcelllymphoma
AT machadomachadopatricia pb2353prognosticvalueoftimefromsymptomsbegintostarttreatmentindiffuselargebcelllymphoma
AT garciamiguelteodorohernandez pb2353prognosticvalueoftimefromsymptomsbegintostarttreatmentindiffuselargebcelllymphoma
AT rayajosemaria pb2353prognosticvalueoftimefromsymptomsbegintostarttreatmentindiffuselargebcelllymphoma